Educational material. This is not medical advice, not a self-medication guide, and not a purchase page. Longeva does not sell Cerebrolysin.

The query "Cerebrolysin instructions" usually means understanding the official patient leaflet for a registered medicine. Below is an educational decode: what the drug is, which forms and indications the manufacturer declares, what independent reviews say, and how that differs from Semax/Selank research samples (RUO) that Longeva lists.

Commercial sibling with pricing: price and forms. Cluster: overview, reviews, shelf: brain peptides.

What Cerebrolysin is and why read the leaflet

Cerebrolysin is a registered prescription medicine described as a peptide hydrolysate of brain tissue (per the manufacturer SmPC). A physician prescribes it; it is not an RUO vial with COA from our shop.

Registered drug vs research material

Semax and Selank in our catalog are defined synthetic peptides marked research use only (RUO), with third-party COA per batch. That is a different substance class from the biological hydrolysate in Cerebrolysin. We do not claim one is "better" or a clinical substitute for the other.

Composition and forms per the leaflet

The official SmPC lists injectable ampoules in several volumes (typical lines include 1 mL, 2 mL, 5 mL, 10 mL; confirm the current register text). We do not duplicate dosing figures here as recommendations.

Registered indications

Ukrainian registration materials list neurological indications including stroke sequelae, vascular dementia, traumatic brain injury, and cognitive impairment within declared groups (worded as "per registration the manufacturer states…", not as Longeva's endorsement). Use is physician-led only.

What the evidence says

Independent Cochrane reviews rate the evidence limited or uncertain. For acute ischaemic stroke, the 2023 review found insufficient basis to conclude clinical benefit [1]. For vascular dementia, the 2019 review also describes a limited picture [2]. That is not a guarantee of ineffectiveness, but it does not support consumer certainty claims either.

Administration and cautions (no self-medication)

Cerebrolysin is a prescription injectable. Route, schedule, and duration are set by a physician per the official leaflet. We do not describe injection protocols, "personal" dosing, or self-administration technique.

Why it is prescription-only

Rx status means a clinician decides therapy after assessing the patient, not a blog post or forum thread.

Cerebrolysin vs nootropic peptides

Cerebrolysin is a complex mixture from a biological source. Semax (ACTH(4-10) derivative) and Selank (tuftsin analogue) are separate synthetic sequences with different mechanisms in the literature. For lab planning, structural definition of the RUO vial matters more than "which is better for a person".

Research materials Longeva offers

How to read COA: HPLC and MS.

FAQ

What is Cerebrolysin? A registered injectable medicine; not an RUO reagent.

Prescription required? Yes in Ukraine.

Does Longeva sell it? No. We offer Semax/Selank and other RUO SKUs.

Summary

This page decodes the official leaflet without price or self-medication. For RUO procurement see brain peptides shelf.

Educational material only; consult a physician for Cerebrolysin.

References

[1] Ziganshina LE et al. Cerebrolysin for acute ischaemic stroke. Cochrane Database Syst Rev. 2023. doi:10.1002/14651858.CD007026.pub7

[2] Chen N et al. Cerebrolysin for vascular dementia. Cochrane Database Syst Rev. 2019. doi:10.1002/14651858.CD008900.pub3